iconiifl-logo-icon 1
IIFL

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth-based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required
sidebar image

Aster DM Healthcare, Faruk Medical City to jointly develop healthcare services in Iraq

7 Dec 2022 , 03:44 PM

Aster DM Healthcare

Aster DM Healthcare has agreed to collaborate on capability development and academic and professional training programmes for clinical staff and healthcare professionals in Iraq with Faruk Medical City, Iraq's leading healthcare service provider.

Faruk Medical City is a subsidiary of Faruk Investment Group, one of Iraq's largest investment firms.

Doctors from Aster DM Healthcare will visit Faruk Medical City's cutting-edge facilities to consult and provide surgical services that are not available locally and require patients to travel overseas.

Aster DM Healthcare and Faruk Medical City will collaborate to provide medical and paramedical staff at Faruk Medical City with training and academic support.

The move aims to jointly develop Faruk Medical City as an excellent hospital by providing advanced academic training and capability development, as well as benchmarked international standards in providing first-rate clinical and medical services in Iraq. Aster will also advise Faruk Medical City on how to apply for international accreditation, said the company on Wednesday.

Faruk Investment Group and Aster DM Healthcare have also signed a Memorandum of Understanding to investigate potential collaboration opportunities to expand Aster Pharmacy's services to Iraq, including pharmaceutical and wellness product distribution and retail.

At around 3.21 PM, Aster DM Healthcare was trading at Rs233.05 up by 2.55% from its previous closing of Rs227.25 on the BSE. The scrip touched intraday high and low of Rs235.15 and Rs227.50 respectively.

For feedback and suggestions, write to us at editorial@iifl.com

Related Tags

  • Aster DM Faruk Medical City
  • Aster DM MoU
  • AsterDM
  • AsterDM Partnership
  • AsterDMShare
  • AsterDMSharePrice
  • AsterDMStock
sidebar mobile

BLOGS AND PERSONAL FINANCE

Images
28 Mar 2024   |   01:21 PM
Images
28 Mar 2024   |   01:02 PM
Images
28 Mar 2024   |   12:43 PM
Images
28 Mar 2024   |   12:37 PM
Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.